NewsEuropeAs Six-Year Legal Battle Nears End French Cannabis...

As Six-Year Legal Battle Nears End French Cannabis Pioneer Outlines Vision For Europe’s CBD Future


ONE of the French entrepreneurs locked in a six-year court battle over the legality of a CBD product has spoken of relief, and hopes the ruling will boost Europe’s hemp industry.

BACK in 2014 Antonin Cohen and his business partners Valentin Squirelo and Sébastien Béguerie introduced the KanaVape to Europe’s shops.

The French entrepreneurs and cannabis advocates had spent years researching and fine-tuning it, believing their CBD e-cigarette to be beneficial – and legal.

Antonin Cohen.

But, the French authorities thought differently as it contained a CBD isolate imported from the Czech Republic extracted from the whole hemp plant.

In France, one of Europe’s main hemp growers, only the seeds and the stalks can be used. The flowers and the leaves, where most of the plant’s cannabinoids are found, must be destroyed.

Mr Cohen told BusinessCann: “When our product was launched in 2014, CBD was almost unknown. Our goal has always been to market a useful and legal product, and we had carried out a legal analysis to validate the conformity of CBD in our product. 

“While it was very difficult to fight these legal challenges for so long we felt compelled to continue, as it is vital to create clear regulations to protect the health of consumers, and to support the competitiveness of French and European companies in a rapidly growing global CBD industry.” 

‘Relief’ As Six-Year Battle Nears End

The French legal process resulted in Mr Cohen and Mr Béguerie receiving a 16-month suspended prison sentence, and a Euro 10,000 fine. Later a French appeal court asked for clarity from the Court of Justice of the European Union (ECJ).

As reported earlier in BusinessCann, in a non-binding opinion for the ECJ, Advocate General Evgeni Tanchev said cannabidiol, or CBD, isn’t a ‘narcotic’ drug. 

As such, CBD oil products made from the whole hemp plant can be traded freely across the member states of the European Union under the existing Freedom of Movement of Goods rules.

Advisory opinions are not binding on the ECJ, but their legal reasoning is followed in about 80% of cases.

From a personal point of view, this opinion is a real relief. It’s been a long journey, and I think a good step-in the right direction. A lot of hard work is starting to pay off

Antonin Cohen

And, if ratified, this would be be a massive boost for European hemp farmers and CBD companies, as most cannabidiol (CBD) is found in the leaves and flowers of the hemp plant.

“From a personal point of view, this opinion is a real relief. It’s been a long journey, and I think a good step in the right direction. A lot of hard work is starting to pay off,” said Mr Cohen.

Will This Open Up Europe To Hemp Flowers?

Mr Cohen continued: “Now we are going to wait for the verdict of the ECJ It’s a very positive signal, creating very exciting possibilities for CBD in Europe.

“At the moment, in France, it is very difficult to use natural CBD because we are only allowed to use CBD from fibre and seeds but this ruling states that CBD from the whole plant can be traded across the whole of the EU, based on Freedom of Movement.

“That is very good news for France and the other European countries that have the same interpretation as France on this topic of the origins of CBD and the parts of the plant that are used.

“I think it could eventually have an impact on the market for hemp flowers, too. There is no reason why this ruling and the rules on Freedom of Movement should not also apply to them.”

Clarity Needed On Euro CBD Content

Advocate General Tanchev went on to say that if a national court found there were ‘risks’ associated with CBD they should look to impose less restrictive measures than blocking the free movement of goods, ‘such as the establishment of a maximum CBD content’.

Mr Cohen continued: “This guidance on CBD content is what we need in the CBD industry. Because of the lack of standards, the market is full of products that display CBD content in many different ways – or that don’t apply basic quality control. It’s very confusing for the consumers. 

“We need better guidelines for the commercialization of CBD products in Europe, for example; packaging, advertisement, licensing.

“The CBD industry is booming in the US, but its development is limited in Europe because it is very difficult to navigate in such a fragmented market, with many different interpretations of international laws applied on national level. 

“We need a harmonization of the regulations by the European Union. We need quality standards and large accessibility of CBD products to protect the health of European users, and the competitiveness of European companies.

“It’s so important to create specific regulations across the CBD industry to ensure safety and quality for all users.”

Implications For Novel Food Applications

Mr Cohen also believes the ruling may help companies looking to submit Novel Food applications placate reluctant national regulators.

He continued: “There are many challenges in the European CBD market and the origins of CBD is just one of them.

“If it was a block to some Novel Food applications, this ruling clarifies this point and might allow some applications currently on hold to proceed.”

Mr Cohen now runs Harmony, one of Europe’s leading CBD brands, and it is moving ahead with its Novel Food applications. For access to the UK market it needs to be submitted by March 31, 2021.

He said: “We are working with laboratory to submit the necessary safety data, most of studies have been done and we will be ready in time.”

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

German Prohibitionists Lobby EU, German Medical Cannabis Re-Think, High Court Blow For Irish CBD, Hemp Batteries In Electric Vehicles?

GERMAN opponents of its adult-use cannabis programme are taking their fight to Brussels in a bid to scupper the...

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing the Maltese Government is set to undermine its commitment to...

Brains Bio Receives NSF’s First CBD Certification For EU GMP CBD API

PRESS RELEASE BRAINS Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in EU GMP grade Cannabidiol (CBD) has...

Amsterdam Cannabis Expo 2022 Latest Scam To Target Industry

AN upcoming European cannabis conference, at which 10,000 cannabis companies were purportedly due to visit, is thought to be...

Juicy Fields Scam May Have Been Small Part Of A Much Larger Criminal Enterprise Says Lawyer As He Prepares To Make Evidence Public

JUICY Fields has already been called the biggest scam in Europe for ‘many, many years’, and its impact on...

Must read

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last...

You might also likeRELATED
Recommended to you